Jesper Vilandt

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Colonoscopy 87%
3. Biomarkers 67%
4. Appendicitis 44%
5. Laparoscopy 38%
6. Blood Proteins 26%
7. Multicenter Studies 26%
8. Early Detection of Cancer 25%
9. Colonic Pseudo-Obstruction 24%
10. Randomized Controlled Trials 24%
11. Neoplasms 23%
12. Proteins 22%
13. Hematologic Tests 22%
14. Adenoma 22%
15. Triage 19%
16. Emergencies 19%
17. Postoperative Nausea and Vomiting 19%
18. Area Under Curve 19%
19. Complement System Proteins 19%
20. Colonic Neoplasms 19%
21. Appendectomy 18%
22. Methylprednisolone 16%
23. Serologic Tests 16%
24. Emergency Medical Services 15%
25. Endoscopy 15%
26. Postoperative Pain 15%
27. Mortality 14%
28. Standard of Care 14%
29. Ferritins 14%
30. Dexamethasone 13%
31. Compliance 13%
32. Denmark 13%
33. Risk Assessment 12%
34. Longitudinal Studies 12%
35. Population 12%
36. Tumor Biomarkers 12%
37. Occult Blood 12%
38. Galectin 3 12%
39. Organizational Efficiency 11%
40. ficolin 11%
41. Collectins 10%
42. Pain 10%
43. Cohort Studies 10%
44. Reproducibility of Results 10%
45. Postoperative Care 10%
46. Pepsinogen A 9%
47. Demography 9%
48. Drug Therapy 8%
49. Placebos 8%
50. Tissue Inhibitor of Metalloproteinase-1 8%